Report cover image

Pharmaceuticals Top 5 Emerging Markets Industry Guide 2019-2028

Publisher MarketLine
Published Sep 20, 2024
Length 322 Pages
SKU # MTLN19325944

Description

Pharmaceuticals Top 5 Emerging Markets Industry Guide 2019-2028


Summary

The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • These countries contributed $262.3 billion to the global pharmaceuticals industry in 2023, with a compound annual growth rate (CAGR) of 6.4% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $337.0 billion in 2028, with a CAGR of 5.1% over the 2023-28 period.
  • Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $161.0 billion in 2023. This was followed by India and Brazil with a value of $48.0 and $30.7 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $217.4 billion in 2028, followed by India and Brazil with expected values of $56.0 and $34.9 billion, respectively.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to Buy
  • What was the size of the emerging five pharmaceuticals market by value in 2023?
  • What will be the size of the emerging five pharmaceuticals market in 2028?
  • What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the emerging five pharmaceuticals market?

Table of Contents

322 Pages
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Top 5 Emerging Countries Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Pharmaceuticals in Brazil
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Macroeconomic Indicators
6.1. Country data
7 Pharmaceuticals in China
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
8 Macroeconomic Indicators
8.1. Country data
9 Pharmaceuticals in India
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
10 Macroeconomic Indicators
10.1. Country data
11 Pharmaceuticals in Mexico
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis
12 Macroeconomic Indicators
12.1. Country data
13 Company Profiles
13.1. BASF SE
13.2. Sinopharm Group Co Ltd
13.3. F. Hoffmann-La Roche Ltd
13.4. The Procter & Gamble Co
13.5. Shanghai Pharmaceuticals Holding Co Ltd
13.6. CSPC Pharmaceutical Group Ltd
13.7. Takeda Pharmaceutical Co Ltd
13.8. Novartis AG
13.9. GSK plc
13.10. AstraZeneca Plc
13.11. Sanofi
13.12. Roche Holding AG
13.13. Laboratoires Pierre Fabre SA
13.14. Ipsen SA
13.15. Les Laboratoires Servier SAS
13.16. Bayer AG
13.17. Boehringer Ingelheim GmbH
13.18. CSL Ltd
13.19. Astrazeneca Pty Ltd
13.20. Mayne Pharma Group Ltd
13.21. Hypera SA
13.22. Ache Laboratorios Farmaceuticos SA
13.23. EMS Sigma Pharma
13.24. Eurofarma Laboratorios SA
13.25. Johnson & Johnson
13.26. Sanofi-Aventis Canada Inc
13.27. Apotex Inc
13.28. Bausch Health Companies Inc
13.29. Jiangsu Hengrui Medicine Co Ltd
13.30. Lupin Ltd
13.31. Cipla Ltd
13.32. Dr. Reddy's Laboratories Ltd
13.33. PT Kalbe Farma Tbk
13.34. PT Kimia Farma Tbk
13.35. PT Tempo Scan Pacific Tbk
13.36. Pfizer Italia Srl
13.37. A. Menarini Industrie Farmaceutiche Riunite Srl
13.38. Chiesi Farmaceutici SpA
13.39. Recordati SpA
13.40. Daiichi Sankyo Co Ltd
13.41. Astellas Pharma Inc
13.42. Otsuka Holdings Co Ltd
13.43. Sanofi-Aventis de Mexico SA de CV
13.44. Genomma Lab Internacional SAB de CV
13.45. Bayer de Mexico SA de CV
13.46. Boehringer Ingelheim Mexico
13.47. Pfizer BV
13.48. Astellas Pharma Europe Ltd
13.49. Merck & Co Inc
13.50. AbbVie Inc
13.51. Pfizer Inc
13.52. Bristol-Myers Squibb Co
13.53. OTC Pharma International BV
13.54. Pharmstandard
13.55. Binnopharm Group
13.56. Novo Nordisk AS
13.57. H. Lundbeck AS
13.58. Pfizer Laboratories (Pty) Ltd
13.59. Aspen Pharmacare Holdings Ltd
13.60. Adcock Ingram Holdings Ltd
13.61. Chong Kun Dang Pharmaceutical Corp.
13.62. Yuhan Corp
13.63. Celltrion Inc
13.64. Hanmi Pharmaceuticals Co Ltd
13.65. Grifols SA
13.66. Almirall SA
13.67. Laboratorios Farmaceuticos Rovi SA
13.68. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
13.69. Deva Holding AS
14 Appendix
14.1. Methodology
14.2. About MarketLine
List of Tables
Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2019-28
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2019-23
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2023-28
Table 4: South Africa pharmaceuticals market value: $ billion, 2018-23
Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2023
Table 6: South Africa pharmaceuticals market value forecast: $ billion, 2023-28
Table 7: South Africa Size of Population (million), 2019-23
Table 8: South Africa real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 9: South Africa GDP (Current Prices, $ Billion), 2019-23
Table 10: South Africa Inflation, 2019-23
Table 11: South Africa Consumer Price Index (Absolute), 2019-23
Table 12: South Africa exchange rate, 2018-23
Table 13: Brazil pharmaceuticals market value: $ billion, 2018-23
Table 14: Brazil pharmaceuticals market geography segmentation: $ billion, 2023
Table 15: Brazil pharmaceuticals market value forecast: $ billion, 2023-28
Table 16: Brazil Size of Population (million), 2019-23
Table 17: Brazil real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 18: Brazil GDP (Current Prices, $ Billion), 2019-23
Table 19: Brazil Inflation, 2019-23
Table 20: Brazil Consumer Price Index (Absolute), 2019-23
Table 21: Brazil exchange rate, 2018-23
Table 22: China pharmaceuticals market value: $ billion, 2018-23
Table 23: China pharmaceuticals market geography segmentation: $ billion, 2023
Table 24: China pharmaceuticals market value forecast: $ billion, 2023-28
Table 25: China Size of Population (million), 2019-23
Table 26: China real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 27: China GDP (Current Prices, $ Billion), 2019-23
Table 28: China Inflation, 2019-23
Table 29: China Consumer Price Index (Absolute), 2019-23
Table 30: China exchange rate, 2018-23
Table 31: India pharmaceuticals market value: $ billion, 2018-23
Table 32: India pharmaceuticals market geography segmentation: $ billion, 2023
Table 33: India pharmaceuticals market value forecast: $ billion, 2023-28
Table 34: India Size of Population (million), 2019-23
Table 35: India real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 36: India GDP (Current Prices, $ Billion), 2019-23
Table 37: India Inflation, 2019-23
Table 38: India Consumer Price Index (Absolute), 2019-23
Table 39: India exchange rate, 2018-23
Table 40: Mexico pharmaceuticals market value: $ billion, 2018-23
Table 41: Mexico pharmaceuticals market geography segmentation: $ billion, 2023
Table 42: Mexico pharmaceuticals market value forecast: $ billion, 2023-28
Table 43: Mexico Size of Population (million), 2019-23
Table 44: Mexico real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 45: Mexico GDP (Current Prices, $ Billion), 2019-23
Table 46: Mexico Inflation, 2019-23
Table 47: Mexico Consumer Price Index (Absolute), 2019-23
Table 48: Mexico exchange rate, 2018-23
Table 49: BASF SE: key facts
Table 50: BASF SE: Annual Financial Ratios
Table 51: BASF SE: Key Employees
Table 52: Sinopharm Group Co Ltd: key facts
Table 53: Sinopharm Group Co Ltd: Annual Financial Ratios
Table 54: Sinopharm Group Co Ltd: Key Employees
Table 55: F. Hoffmann-La Roche Ltd: key facts
Table 56: F. Hoffmann-La Roche Ltd: Key Employees
Table 57: The Procter & Gamble Co: key facts
Table 58: The Procter & Gamble Co: Annual Financial Ratios
Table 59: The Procter & Gamble Co: Key Employees
Table 60: The Procter & Gamble Co: Key Employees Continued
Table 61: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 62: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 63: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 64: CSPC Pharmaceutical Group Ltd: key facts
Table 65: CSPC Pharmaceutical Group Ltd: Annual Financial Ratios
Table 66: CSPC Pharmaceutical Group Ltd: Key Employees
Table 67: Takeda Pharmaceutical Co Ltd: key facts
Table 68: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
Table 69: Takeda Pharmaceutical Co Ltd: Key Employees
Table 70: Takeda Pharmaceutical Co Ltd: Key Employees Continued
Table 71: Novartis AG: key facts
Table 72: Novartis AG: Annual Financial Ratios
Table 73: Novartis AG: Key Employees
Table 74: GSK plc: key facts
Table 75: GSK plc: Annual Financial Ratios
Table 76: GSK plc: Key Employees
Table 77: AstraZeneca Plc: key facts
Table 78: AstraZeneca Plc: Annual Financial Ratios
Table 79: AstraZeneca Plc: Key Employees
Table 80: Sanofi: key facts
Table 81: Sanofi: Annual Financial Ratios
Table 82: Sanofi: Key Employees
Table 83: Sanofi: Key Employees Continued
Table 84: Roche Holding AG: key facts
Table 85: Roche Holding AG: Annual Financial Ratios
Table 86: Roche Holding AG: Key Employees
Table 87: Laboratoires Pierre Fabre SA: key facts
Table 88: Laboratoires Pierre Fabre SA: Key Employees
Table 89: Ipsen SA: key facts
Table 90: Ipsen SA: Annual Financial Ratios
Table 91: Ipsen SA: Key Employees
List of Figures
Figure 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2019-28
Figure 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2019-23
Figure 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2023-28
Figure 4: South Africa pharmaceuticals market value: $ billion, 2018-23
Figure 5: South Africa pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 6: South Africa pharmaceuticals market value forecast: $ billion, 2023-28
Figure 7: Forces driving competition in the pharmaceuticals market in South Africa, 2023
Figure 8: Drivers of buyer power in the pharmaceuticals market in South Africa, 2023
Figure 9: Drivers of supplier power in the pharmaceuticals market in South Africa, 2023
Figure 10: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2023
Figure 11: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2023
Figure 12: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2023
Figure 13: Brazil pharmaceuticals market value: $ billion, 2018-23
Figure 14: Brazil pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 15: Brazil pharmaceuticals market value forecast: $ billion, 2023-28
Figure 16: Forces driving competition in the pharmaceuticals market in Brazil, 2023
Figure 17: Drivers of buyer power in the pharmaceuticals market in Brazil, 2023
Figure 18: Drivers of supplier power in the pharmaceuticals market in Brazil, 2023
Figure 19: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2023
Figure 20: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2023
Figure 21: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2023
Figure 22: China pharmaceuticals market value: $ billion, 2018-23
Figure 23: China pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 24: China pharmaceuticals market value forecast: $ billion, 2023-28
Figure 25: Forces driving competition in the pharmaceuticals market in China, 2023
Figure 26: Drivers of buyer power in the pharmaceuticals market in China, 2023
Figure 27: Drivers of supplier power in the pharmaceuticals market in China, 2023
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2023
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2023
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in China, 2023
Figure 31: India pharmaceuticals market value: $ billion, 2018-23
Figure 32: India pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 33: India pharmaceuticals market value forecast: $ billion, 2023-28
Figure 34: Forces driving competition in the pharmaceuticals market in India, 2023
Figure 35: Drivers of buyer power in the pharmaceuticals market in India, 2023
Figure 36: Drivers of supplier power in the pharmaceuticals market in India, 2023
Figure 37: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2023
Figure 38: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2023
Figure 39: Drivers of degree of rivalry in the pharmaceuticals market in India, 2023
Figure 40: Mexico pharmaceuticals market value: $ billion, 2018-23
Figure 41: Mexico pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 42: Mexico pharmaceuticals market value forecast: $ billion, 2023-28
Figure 43: Forces driving competition in the pharmaceuticals market in Mexico, 2023
Figure 44: Drivers of buyer power in the pharmaceuticals market in Mexico, 2023
Figure 45: Drivers of supplier power in the pharmaceuticals market in Mexico, 2023
Figure 46: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2023
Figure 47: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2023
Figure 48: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us